MPI Research is proud to announce the opening of its new Analytical Laboratory. The new laboratory will initially support the Test Material Formulations, Inhalation and Metabolism groups within MPI Research. Stefan Nyarady, Ph.D. heads up the Analytical Laboratory. This brand new GLP facility is equipped with Waters HPLCs and is capable of performing all necessary analyses related to test article homogeneity, concentration, and stability. The new laboratory will also conduct analytical method validations necessary to meet our sponsors’ needs.

James Laveglia, Ph.D., Executive Vice President and Director of Research, commented, “the opening of this new laboratory within MPI Research emphasizes our responsiveness to our sponsors’ desire for us to add services in support of their non-clinical efforts. Over the course of the next year, we will add bioanalytical capabilities to the new laboratory. We are constantly working to become a full service non-clinical facility and this is an important step in that direction.”

MPI Research exists to provide comprehensive non-clinical research that meets the requirements of pharmaceutical, animal health and chemical companies as well as governmental agencies as we partner together to bring safer, healthier products to the world. MPI employees specialize in a wide variety of scientific disciplines including toxicology, pharmacology, metabolism, pathology, clinical pathology, reproductive and developmental biology, veterinary science, neuroscience, analytical chemistry, computer science, regulatory science, and statistics.

Home | News